Shionogi Inc., the U.S. subsidiary of Shionogi & Co. Ltd., announced June 2 that current President and CEO Akira Kato will leave the Florham Park division to lead the parent company in Japan. With his ...

But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look ...

TOKYO, May 13 (Reuters) - Japan's Shionogi & Co (4507.T), opens new tab said on Monday its pill-based treatment for COVID-19 did not meet the primary endpoint of showing a statistically significant ...

Shionogi Inc., a United States subsidiary of Shionogi & Co., Ltd., (Head Office: Osaka, Japan; Chief Executive Officer: Isao Teshirogi, Ph.D.), will share17 scientific presentations from across its ...

As the fight against COVID-19 rolls on, regulators in Japan have bestowed a green light on the country's first homegrown antiviral. The win goes to local drugmaker Shionogi, which has clinched an ...

In a high-stakes game for both companies, Shionogi is doubling down on its Tetra Therapeutics R&D deal with a buyout option wedded to key data coming out this month. The pair’s original pact was ...

Shionogi will also become a 10% shareholder in ViiV Healthcare and will be entitled to a proportional share of ordinary dividends paid. Shionogi will be entitled to representation on the ViiV ...

Shionogi (TSE:4507) shares have moved quietly over the past month, with limited news driving investor sentiment. Despite a lack of major headlines, recent price action has caught the attention of ...

ViiV Healthcare acquires exclusive global rights to HIV integrase inhibitor portfolio, including dolutegravir Shionogi receives ongoing royalty and dividend stream and receives 10% equity in ViiV ...

Shionogi & Co. will partner with Sage Therapeutics to develop and commercialize Sage’s SAGE-217 to treat major depressive disorder (MDD) and other indications in Japan, Taiwan, and South Korea, ...

For most drugmakers, it pays to focus on high-priced drugs in new treatment areas. But Japan’s Shionogi is counting on the opposite. Shionogi CEO Isao Teshirogi told Bloomberg that the company, which ...

FLORHAM PARK, N.J.--(BUSINESS WIRE)--Shionogi Inc., a pharmaceutical company with a significant focus on infectious diseases, announced today the expanded leadership roles of executive vice president ...